Dotarem Received FDA Approval For MRIs of Nervous System

14 February 2013

Categorized | FDA Approvals Dotarem Received FDA Approval For MRIs of Central Nervous System   What’s New: FDA has approved Dotarem (gadoterate meglumine) to be used as a contrast agent in MRIs of various parts of the central nervous system such as spine and brain. Important Detail: The Food and Drug Administration of the United […]

Read the full story

Post by admin FDA Approvals 0 Comments